Skip to Content
Merck
  • L-plastin enhances NLRP3 inflammasome assembly and bleomycin-induced lung fibrosis.

L-plastin enhances NLRP3 inflammasome assembly and bleomycin-induced lung fibrosis.

Cell reports (2022-03-17)
Hemant Joshi, Alison Almgren-Bell, Edgar P Anaya, Elizabeth M Todd, Steven J Van Dyken, Anushree Seth, Katherine M McIntire, Srikanth Singamaneni, Fayyaz Sutterwala, Sharon C Morley
ABSTRACT

Macrophage adhesion and stretching have been shown to induce interleukin (IL)-1β production, but the mechanism of this mechanotransduction remains unclear. Here we specify the molecular link between mechanical tension on tissue-resident macrophages and activation of the NLRP3 inflammasome, which governs IL-1β production. NLRP3 activation enhances antimicrobial defense, but excessive NLRP3 activity causes inflammatory tissue damage in conditions such as pulmonary fibrosis and acute respiratory distress syndrome. We find that the actin-bundling protein L-plastin (LPL) significantly enhances NLRP3 assembly. Specifically, LPL enables apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC) oligomerization during NLRP3 assembly by stabilizing ASC interactions with the kinase Pyk2, a component of cell-surface adhesive structures called podosomes. Upon treatment with exogenous NLRP3 activators, lung-resident alveolar macrophages (AMs) lacking LPL exhibit reduced caspase-1 activity, IL-1β cleavage, and gasdermin-D processing. LPL-/- mice display resistance to bleomycin-induced lung injury and fibrosis. These findings identify the LPL-Pyk2-ASC pathway as a target for modulation in NLRP3-mediated inflammatory conditions.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
PF-431396 hydrate, ≥98% (HPLC)
Sigma-Aldrich
Fetal Bovine Serum, USA origin, sterile-filtered, suitable for cell culture, suitable for hybridoma